Tianyin has received approval from the Chinese State Food and Drug Administration (SFDA) to produce Sanqi Tablets in dosage form of 0.5gm/tablet, and Yinqiao Jiedu Tablets in dosage
Herbalife has sealed an agreement to buy certain assets of Micelle Laboratories (Micelle), in order to strengthen its global manufacturing capabilities. The Micelle facility is FDA-certified and is
Bio-Matrix Scientific Group (BMSN) has entered into a Letter of Intent (LOI) with Therinject contemplating the development of a new immuno-therapeutic cancer vaccine. The LOI, which is subject
King Pharmaceuticals (King) has received FDA approval for Embeda (morphine sulfate and naltrexone hydrochloride) extended release capsules for oral use. Embeda, a long-acting opioid that is designed to
Nutra Pharma has announced that its wholly-owned drug discovery subsidiary, ReceptoPharm, has filed a patent for a novel composition and method for oral delivery of cobra venom, for
Sales of patch products rose moderately to $9.9 million in the second quarter of 2009, accounting for 30.9% of revenue, compared to 37% a year ago. Sales of
The US Food and Drug Administration has accepted to file Theratechnologies’ New Drug Application (NDA) for its lead compound, tesamorelin. Under the terms of the company’s collaboration and
Arrayit said that Arrayit Diagnostics Inc. will spearhead an intensive marketing campaign in an effort to establish Arrayit in the diagnostics sector.
Clinical Data has entered into a collaboration and licensing agreement with CombinatoRx to develop an adenosine A2A agonist compound in a combination therapy. It is intended for the
Palatin Technologies (Palatin) has completed phase 1 clinical trial of bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.